Wednesday, October 28, 2026
News

Fios Genomics bioinformatics team and services move to Excelra

SocialTwist Tell-a-Friend    Print this Page   COMMENT

| October 28, 2026 10:41:20 IST
PRNewswire

Edinburgh [Scotland] / Hyderabad (Telangana) [India], October 28: Excelra, a global scientific informatics company, today announced that the bioinformatics services of Fios Genomics Ltd, and the team behind them, have moved to Excelra with effect from 20 October 2026. Edinburgh-based team joins Excelra's scientific consulting group, strengthening its omics analytics expertise and presence in the UK and Europe.

Fios Genomics, based in Edinburgh, has spent nearly two decades turning complex omics data into impactful insights for pharma, biotech, and other life science researchers, with particular depth in multi-omics study analysis. The team joins Excelra's wider scientific consulting group and will continue to serve Fios clients with the same scientists and the same platform.

"This is about continuity and making a larger impact for our clients," said Sarah Lynagh, CEO of Fios Genomics. "Fios has always been defined by the quality of its science and the care we take with each study. Excelra shares those values and brings the wider data science and scientific informatics capability to do more for the researchers we work with."

"Fios is known for rigorous, study-level analysis delivered quickly and explained clearly, exactly what researchers need when a dataset lands," said Jannick Bendtsen, Vice President Bioinformatics, Excelra. "That way of working fits naturally with our focus on integrative multi-omics, translational insight, and scientific AI. The team now has Excelra's data assets, AI engineering, and a far larger pool of domain specialists behind it."

"Fios has built a team of bioinformaticians that clients trust with their hardest questions, and we are delighted to welcome them to Excelra," said Anandbir Singh Brar, CEO of Excelra. "Omics data keeps growing, but the questions don't change: which target? which indication? which patients? Pairing Fios' scientific depth with our own bioinformatics, data, and AI-native engineering means we can answer those questions even faster and with more confidence."

Fios clients can reach the team at team.fiosgenomics@excelra.com

About ExcelraExcelra engineers trust into AI-driven R&D, combining AI-ready data and platforms, including GOSTAR, connected lab informatics, and multi-omics expertise to turn R&D complexity into decisions you can defend. Science led. Data driven. Outcomes focused.

About Fios GenomicsFounded in 2008 as a University of Edinburgh spin-out, Fios Genomics has delivered bioinformatics analysis and biological interpretation across genomics, transcriptomics and multi-omics studies to pharma, biotech, and life science researchers worldwide.

ContactPrashant Sharmacontact@excelra.com

(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire. ANI will not be responsible in any way for the content of the same.)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Piramal Pharma Limited Announces Results...
SBI Life Insurance registers New Busines...
Global Dignity Day 2026: Mumbai Honours ...
Cabinet approves Rs 10,000 crore contain...
OneConsent and PHDCCI Partner to Advance...
Raymond Realty reports a healthy Q2FY27 ...
More...
 
INDIA WORLD ASIA
Telangana: BRS leader Sabitha Indra Redd...
'SPs PDA is mere mask for dynastic ambi...
'There was a single tender': R Ashoka al...
'PM Modi takes feedback, sets deadlines ...
Shimla Police identify 58 suspected ille...
Rahul Gandhi should take good advice: ...
More...    
 
 Top Stories
‘Pride and Prejudice’ series traile... 
India closely monitoring Tehran tal... 
Prioritise night-time cleaning so d... 
MIAL and AOC Align on phased transi... 
Route "demining" for Oleshky aid mi... 
Rajnath Singh holds bilateral meeti... 
CSMIA Mumbai shares vision for rede... 
Court hears arguments on charges ag...